Why These 5 Stocks Are in the Spotlight on Tuesday

3. Johnson & Johnson (NYSE:JNJ) is up over 0.8% after the company asked the FDA to allow for booster shots for its COVID-19 vaccine, which could increase demand. If demand is higher, Johnson & Johnson (NYSE:JNJ) could find it easier to make profits. The number of elite funds in our database long Johnson & Johnson (NYSE:JNJ) rose by 7 from the prior quarter to 88 at the end of the second quarter.